Cargando…
Paraneoplastic syndromes /
Paraneoplastic syndromes, defined in this book as "disorders caused by cancer, but not a direct result of cancer invasion of the affected organ or tissue", once believed to be rare and esoteric neurologic disorders have assumed increasing importance as an.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford :
Oxford University Press,
2011.
|
| Colección: | Contemporary neurology series ;
79. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; CONTENTS; SECTION 1 OVERVIEW; 1. DEFINITIONS, CLASSIFICATION, HISTORY, EPIDEMIOLOGY, AND IMPORTANCE; DEFINITIONS; CLASSIFICATION; HISTORY; EPIDEMIOLOGY; IMPORTANCE; 2. CLINICAL FINDINGS, DIAGNOSIS, TREATMENT, AND PROGNOSIS; CLINICAL APPROACH; CLUES TO DIAGNOSIS; PATHOLOGY; TREATMENT; PROGNOSIS; 3. PATHOGENESIS; HISTORICAL VIEWS OF PATHOGENESIS; CURRENT CONCEPTS OF PATHOGENESIS; ANIMAL MODELS; SECTION 2 CLINICAL SYNDROMES; 4. CEREBRAL HEMISPHERE SYNDROMES; CEREBRAL CORTEX (NEOCORTEX); WHITE MATTER DEMYELINATION; BLOOD VESSELS (VASCULITIS).
- Hippocampus (limbic encephalitis/encephalopathy)hypothalamus; basal ganglia and thalamus; cognitive and behavioral abnormalities; encephalomyelitis; 5. brainstem and cerebellum; brainstem; cerebellum; 6. spinal cord syndromes; transverse myelopathies; focal myelopathy; movement disorders; 7. cranial nerves; taste and smell (cranial nerves i, v, and vii); visual disturbances (cranial nerve ii); oculomotor nerves (cranial nerves iii, iv, and vi); trigeminal nerve (cranial nerve v); acoustic/vestibular nerve (cranial nerve viii); other cranial nerves; 8. dorsal root ganglia and peripheral nerves.
- Dorsal root gangliaperipheral nerve syndromes; 9. neuromuscular junction and muscle; neuromuscular junction disorders; paraneoplastic muscle disorders; 10. non-neurologic paraneoplastic syndromes; endocrine disorders; rheumatic syndromes; autoimmune syndromes; rheumatic vasculitides; other rheumatic disorders; panniculitis; dermatologic syndromes; bone disorders; systemic disorders; section 3 antibodies; 11. paraneoplastic antinuclear and antinucleolar antibodies; anti-hu (anna-1); anti-ri (anna-2); anti-ma1 ma-2; anna-3; zic-4; sox1 (anti-glial nuclear antibody); 12. cytoplasmic antibodies.
- Anti-yoanti-tr; anti-cv2 (crmp5); anti
- pca-2; anti-kinase antibodies; anti-ubiquitin conjugating enzyme (ube2e1); anti-nb (beta-nap); anti-proteasome; anti-carp viii; 13. synaptic and channel antibodies; intracellular synaptic antibodies; synaptic receptor antibodies; ion channel antibodies; postsynaptic receptor antibodies; 14. anti-retinal and optic nerve antibodies; carcinoma-associated retinopathy; isolated cone dysfunction; melanoma-associated retinopathy; bilateral diffuse uveal melanocytic proliferation; section 4 cancers; 15. thoracic cancers; lung cancer; thymus cancer.
- 16. breast, gynecologic, and testicular cancersgynecologic cancers; breast cancer; testicular cancer; 17. hematologic malignancies and miscellaneous solid tumors; lymphomas and leukemias; melanoma; urinary tract cancers; gastrointestinal cancers; colon cancer; gastric and esophageal cancers; head and neck cancers; sarcomas; histiocytosis; index; a; b; c; d; e; f; g; h; i; k; l; m; n; o; p; r; s; t; u; v; w; y; z.